Liquidia (LQDA) Competitors $14.03 +0.48 (+3.54%) Closing price 04/24/2025 04:00 PM EasternExtended Trading$13.44 -0.59 (-4.23%) As of 07:16 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LQDA vs. NARI, INSP, BLCO, IRTC, SLNO, PRCT, TMDX, NVST, LIVN, and LMATShould you be buying Liquidia stock or one of its competitors? The main competitors of Liquidia include Inari Medical (NARI), Inspire Medical Systems (INSP), Bausch + Lomb (BLCO), iRhythm Technologies (IRTC), Soleno Therapeutics (SLNO), PROCEPT BioRobotics (PRCT), TransMedics Group (TMDX), Envista (NVST), LivaNova (LIVN), and LeMaitre Vascular (LMAT). These companies are all part of the "medical equipment" industry. Liquidia vs. Inari Medical Inspire Medical Systems Bausch + Lomb iRhythm Technologies Soleno Therapeutics PROCEPT BioRobotics TransMedics Group Envista LivaNova LeMaitre Vascular Liquidia (NASDAQ:LQDA) and Inari Medical (NASDAQ:NARI) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, valuation, earnings, dividends, community ranking, analyst recommendations and risk. Which has preferable earnings and valuation, LQDA or NARI? Inari Medical has higher revenue and earnings than Liquidia. Inari Medical is trading at a lower price-to-earnings ratio than Liquidia, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLiquidia$14.00M85.51-$78.50M-$1.67-8.40Inari Medical$493.63M9.48-$1.64M-$1.35-59.24 Is LQDA or NARI more profitable? Inari Medical has a net margin of -13.68% compared to Liquidia's net margin of -765.38%. Inari Medical's return on equity of -10.09% beat Liquidia's return on equity.Company Net Margins Return on Equity Return on Assets Liquidia-765.38% -163.21% -67.14% Inari Medical -13.68%-10.09%-6.60% Do insiders & institutionals have more ownership in LQDA or NARI? 64.5% of Liquidia shares are held by institutional investors. Comparatively, 91.0% of Inari Medical shares are held by institutional investors. 30.1% of Liquidia shares are held by company insiders. Comparatively, 10.6% of Inari Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the MarketBeat Community believe in LQDA or NARI? Liquidia received 141 more outperform votes than Inari Medical when rated by MarketBeat users. Likewise, 68.77% of users gave Liquidia an outperform vote while only 57.89% of users gave Inari Medical an outperform vote. CompanyUnderperformOutperformLiquidiaOutperform Votes20768.77% Underperform Votes9431.23% Inari MedicalOutperform Votes6657.89% Underperform Votes4842.11% Which has more risk & volatility, LQDA or NARI? Liquidia has a beta of 0.23, meaning that its share price is 77% less volatile than the S&P 500. Comparatively, Inari Medical has a beta of 1.02, meaning that its share price is 2% more volatile than the S&P 500. Does the media prefer LQDA or NARI? In the previous week, Liquidia had 15 more articles in the media than Inari Medical. MarketBeat recorded 15 mentions for Liquidia and 0 mentions for Inari Medical. Inari Medical's average media sentiment score of 1.44 beat Liquidia's score of 1.22 indicating that Inari Medical is being referred to more favorably in the news media. Company Overall Sentiment Liquidia Positive Inari Medical Positive Do analysts prefer LQDA or NARI? Liquidia currently has a consensus price target of $26.63, indicating a potential upside of 89.77%. Inari Medical has a consensus price target of $68.00, indicating a potential downside of 14.97%. Given Liquidia's stronger consensus rating and higher possible upside, equities analysts plainly believe Liquidia is more favorable than Inari Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Liquidia 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.11Inari Medical 0 Sell rating(s) 12 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.14 SummaryLiquidia beats Inari Medical on 10 of the 19 factors compared between the two stocks. Get Liquidia News Delivered to You Automatically Sign up to receive the latest news and ratings for LQDA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LQDA vs. The Competition Export to ExcelMetricLiquidiaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.20B$6.59B$5.41B$7.70BDividend YieldN/A3.21%5.44%4.33%P/E Ratio-8.617.0522.1818.31Price / Sales85.51273.45397.31107.04Price / CashN/A65.6738.2034.62Price / Book19.226.506.834.25Net Income-$78.50M$142.50M$3.20B$247.51M7 Day Performance2.26%8.32%5.77%6.86%1 Month Performance-10.06%-5.61%-4.32%-2.95%1 Year Performance13.42%0.11%17.88%5.17% Liquidia Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LQDALiquidia2.6728 of 5 stars$14.03+3.5%$26.63+89.8%+11.8%$1.20B$14.00M-8.6150News CoverageNARIInari Medical0.659 of 5 stars$79.97flat$68.00-15.0%N/A$4.68B$493.63M-59.24800Upcoming EarningsPositive NewsINSPInspire Medical Systems4.6866 of 5 stars$149.61+1.4%$226.70+51.5%-32.5%$4.45B$802.80M86.481,246Gap UpBLCOBausch + Lomb3.939 of 5 stars$12.25+7.5%$18.82+53.6%-6.7%$4.33B$4.79B-13.4612,500Upcoming EarningsAnalyst ForecastGap UpIRTCiRhythm Technologies1.043 of 5 stars$103.20+1.1%$119.73+16.0%-10.0%$3.24B$591.84M-28.351,790Upcoming EarningsPositive NewsSLNOSoleno Therapeutics4.8179 of 5 stars$70.00+4.1%$99.63+42.3%+88.7%$3.21BN/A-21.0830Analyst ForecastPositive NewsPRCTPROCEPT BioRobotics2.6068 of 5 stars$53.76+3.2%$91.43+70.1%+0.2%$2.95B$224.50M-27.57430Earnings ReportNews CoveragePositive NewsGap UpTMDXTransMedics Group2.6845 of 5 stars$86.84+7.8%$122.70+41.3%+6.0%$2.92B$441.54M92.38210Upcoming EarningsAnalyst ForecastNVSTEnvista4.0836 of 5 stars$15.63+1.1%$20.18+29.1%-21.2%$2.69B$2.51B-2.4112,700Upcoming EarningsGap UpLIVNLivaNova3.6613 of 5 stars$35.46+4.4%$61.17+72.5%-33.4%$1.93B$1.25B84.432,900Upcoming EarningsPositive NewsLMATLeMaitre Vascular2.2924 of 5 stars$83.78+1.2%$95.25+13.7%+43.3%$1.89B$219.86M45.78490Upcoming EarningsPositive News Related Companies and Tools Related Companies Inari Medical Competitors Inspire Medical Systems Competitors Bausch + Lomb Competitors iRhythm Technologies Competitors Soleno Therapeutics Competitors PROCEPT BioRobotics Competitors TransMedics Group Competitors Envista Competitors LivaNova Competitors LeMaitre Vascular Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LQDA) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Liquidia Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Liquidia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LQDA Stock Free LQDA Stock Alerts